Pharmaceuticals Global On demand · 24-48h

Global Grape Seed Extract Tablets Market Strategic Research Report

Global Grape Seed Extract Tablets Market Strategic Research …
$3,500 USD
Market Research Reports
Strategic Research Report
Global Grape Seed Extract Tablets Market
$1.48B2025
7.1%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Standard Grape Seed Tablet, High-OPC Grape Seed Tablet, Others

By Application: Skin anti-aging, Cardiovascular health protection, Immune support

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Swisse, RZRKC, BESICA, GNC, Wnzoey, HealthyCare, BYHEALTH, Anthogenol, NewEast, Conba, Puritan's Pride, TRT, Thompson's, BAIHEKANG, GO Healthy

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 112 pages
Market size 2025
$1.48B
Billion USD
Forecast CAGR
7.1%
2025-2032
Forecast 2032
$2.4B
Projected
Regions
5
Asia Pacific · Latin America · MEA · Europe · North America

Overview

Scope of the Report

The global Grape Seed Extract Tablets market size is predicted to grow from US$ 1,484 million in 2025 to US$ 2,370 million in 2032; it is expected to grow at a CAGR of 7.1% from 2026 to 2032.

In 2024, the global annual production capacity of grape seed extract tablets reached approximately 95 million bottles, while the actual output was around 78.9 million bottles. The average market price was roughly US$18 per bottle, and major manufacturers maintained gross profit margins between 30% and 45%.Grape Seed Extract Tablets are dietary supplements made from concentrated proanthocyanidins (OPCs) extracted from grape seeds. They are used for antioxidant support, skin health, cardiovascular protection, and immune enhancement.

Upstream includes grape seed raw materials, extraction technology (solvent extraction, membrane separation), tablets/encapsulation materials, and active ingredient suppliers. Midstream manufacturers include nutraceutical contract manufacturers and supplement brands across the US, EU, and China. Downstream consists of pharmacies, e-commerce platforms, nutrition stores, and beauty/anti-aging clinics.

The global market for grape seed extract tablets continues to expand due to rising consumer interest in anti-aging, cardiovascular health, and natural antioxidants. OPCs are widely recognized for their anti-inflammatory and free-radical-scavenging properties, driving strong adoption among middle-aged and elderly consumers. Growth is further supported by clean-label trends and increased availability through e-commerce channels. Emerging markets in Asia are showing accelerated demand, particularly in China, driven by beauty and skin-care health awareness. Manufacturers focus on improving extraction purity, stabilizing OPC content, and producing high-potency formulations. Strong marketing related to skin brightening and microcirculation support also contributes to market expansion.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Grape Seed Extract Tablets market?

What factors are driving Grape Seed Extract Tablets market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Grape Seed Extract Tablets market opportunities vary by end market size?

How does Grape Seed Extract Tablets break out by Type, by Application?

This report presents a comprehensive overview of the global Grape Seed Extract Tablets market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Standard Grape Seed Tablet
  • High-OPC Grape Seed Tablet
  • Others

Segment by Added Ingredient

  • Single Grape Seed Tablet
  • Grape Seed + Vitamin C Tablet
  • Grape Seed + Niacinamide Tablet
  • Others

Segment by Application

  • Skin anti-aging
  • Cardiovascular health protection
  • Immune support

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Grape Seed Extract Tablets market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Skin anti-aging, Cardiovascular health protection, Immune support evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Grape Seed Extract Tablets Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 7.1%
Regional growth momentum
Market share by segment
Key metrics
Base value
$1.48B
2025
Forecast
$2.4B
2032
CAGR
7.1%
2025–2032
Regions
5
global
Key companies
SwisseRZRKCBESICAGNCWnzoeyHealthyCareBYHEALTHAnthogenol
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Standard Grape Seed TabletHigh-OPC Grape Seed TabletOthers
By Application
Skin anti-agingCardiovascular health protectionImmune support

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Standard Grape Seed Tablet
  • 3.1.3 High-OPC Grape Seed Tablet
  • 3.1.4 Others
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Skin anti-aging
  • 4.1.3 Cardiovascular health protection
  • 4.1.4 Immune support
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Swisse
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 RZRKC
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 BESICA
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 GNC
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Wnzoey
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 HealthyCare
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 BYHEALTH
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Anthogenol
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 NewEast
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Conba
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Puritan's Pride
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 TRT
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Thompson's
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 BAIHEKANG
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 GO Healthy
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Grape Seed Extract Tablets market size?
The global Grape Seed Extract Tablets market is estimated at US$ 1.48 billion in 2025 (base year) and is projected to reach US$ 2.37 billion by 2032.
What growth rate is expected for the Grape Seed Extract Tablets market through 2032?
The market is expected to grow at a CAGR of 7.1% from 2026 to 2032, expanding from US$ 1.48 billion in 2025 to US$ 2.37 billion in 2032, roughly 1.6 times its base-year value.
How is Grape Seed Extract Tablets defined?
In 2024, the global annual production capacity of grape seed extract tablets reached approximately 95 million bottles, while the actual output was around 78.9 million bottles. The average market price was roughly US$18 per bottle, and major manufacturers maintained gross profit margins between 30% and 45%.Grape Seed Extract Tablets are dietary supplements made from concentrated proanthocyanidins (OPCs) extracted from grape seeds. They are used for antioxidant support, skin health, cardiovascular protection, and immune enhancement.
What are the main segments of the Grape Seed Extract Tablets market by type?
By type, the market is segmented into Standard Grape Seed Tablet, High-OPC Grape Seed Tablet and Others.
Which applications drive demand in the Grape Seed Extract Tablets market?
Key applications covered include Skin anti-aging, Cardiovascular health protection and Immune support.
Who are the key players in the Grape Seed Extract Tablets market?
Key players profiled include Swisse, RZRKC, BESICA, GNC, Wnzoey, HealthyCare, BYHEALTH and Anthogenol, among 15 companies covered in total.
Which regions and countries are covered for Grape Seed Extract Tablets?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Grape Seed Extract Tablets market?
OPCs are widely recognized for their anti-inflammatory and free-radical-scavenging properties, driving strong adoption among middle-aged and elderly consumers.
Who should buy the Grape Seed Extract Tablets market report?
The report is intended for manufacturers and solution providers, distributors and end users in Skin anti-aging, Cardiovascular health protection and Immune support, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Grape Seed Extract Tablets market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

All data sources are cited within the report. View our full research methodology →
Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.